Proven leadership in cardiovascular, metabolic disease and dermatology trials





Integrium Quick Turnaround » Accelerate Your Ambition

At Integrium, we understand the need for speed.
We know that you need answers. Quickly.
We can help you obtain the reliable, accurate data you need to make informed decisions, reach inflection points and make go-no go decisions.
IntegriumQT is dedicated to delivering early phase results fast.
But we’re also proud of our proven track record of delivering results that are consistently accurate, reliable and communicated with clarity and precision.
Generally, in as few as 90 days, we can help you complete:
  • IND Creation
  • Protocol Development
  • IRB Submission
  • Recruiting/Enrollment
  • Study Conduct
  • Topline Results
IntegriumQT conducts Phase I/PK studies:
  • First-in-Human Studies
  • Pharmacokinetics / Pharmacodynamics
  • Single /Multiple Ascending Dose
  • Dose Ranging
  • Maximum Tolerated Dose
  • Bioavailability / Bioequivalence
  • Indication-Specific
  • Proof of Concept
  • Special Populations
  • Thorough QT/QTc
  • Food Effect
  • Drug-Drug Interaction
IntegriumQT accelerated Phase I studies feature:
  • Expert Study Design and Protocol Writing
  • Rapid Enrollment
  • Fully-Equipped 50-Bed Clinical Research Unit with:
    • Extensive Subject Database
    • ECG, ABPM, Holter Monitoring
    • Thorough QT/QTc, Telemetry
    • PK/PD
  • Medical Monitoring
  • Data Management and Biostatistics
  • Clinical Study Reports